ÂÜÀòÂÒÂ×

Daniel Cloutier is currently serving as the Vice President of Drug Development at Revagenix, Inc. Prior to this role, Daniel held positions at companies such as Vir Biotechnology, Inc., Achaogen, and Cubist Pharmaceuticals, where Daniel gained significant experience in clinical research, development, and pharmaceuticals. Daniel completed their Doctor of Pharmacy degree at Massachusetts College of Pharmacy and Health Sciences.